Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout

Fig. 1

a Infusion reactions (IRs) in responders and nonresponders in the groups receiving pegloticase every 2 weeks (Q2w) and every 4 weeks (Q4w). b IRs classified as anaphylaxis, hypersensitivity, or other in the Q2w and Q4w pegloticase dosing groups. c IRs classified as anaphylaxis, hypersensitivity, or other for responders and nonresponders in the Q2w and Q4w pegloticase dosing groups

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us